Vision
Rose Pharma is dedicated to improving the lives of irritable bowel syndrome sufferers by developing targeted treatments for acute pain.
Link to: IBS Health Impact
IBS Health Impact
IBS affects about 11% of the general population, with significant cost and health-related quality of life impacts.
Link to: A Unique Approach
A Unique Approach
Rose’s lead molecule is an NCE analogue of GLP-1, a peptide hormone involved in the regulation of gut motility and pain perception.
Link to: Clinical development
Clinical development
Having completed two Phase IIa studies, Rose is now preparing for a Phase IIb study at sites in the United States.